Director General, IFPMA 

David has over 25 years’ experience in the development and commercialization of medicines for the treatment of infectious diseases, specializing in priority diseases such as HIV/AIDS and pandemic influenza. He is on the Board of the Coalition for Epidemic Preparedness Innovations (CEPI), the RBM Partnership to End Malaria and of the Board of Trustees of Malaria No More UK. He previously served as the CEO of Medicines for Malaria Venture (MMV).